| European Case Law Identifier: |
ECLI:EP:BA:1997:T026993.19971211 |
| Date of decision: |
11 December 1997 |
| Case number: |
T 0269/93 |
| Application number: |
85110622.9 |
| IPC class: |
A61K 31/19 |
| Language of proceedings: |
EN |
| Distribution: |
C |
| Download and more information: |
|
| Title of application: |
Use of 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid for enhancing the effect of anti-tumour agents |
| Applicant name: |
Eisai Co., Ltd. |
| Opponent name: |
- |
| Board: |
3.3.02 |
| Headnote: |
- |
| Relevant legal provisions: |
|
| Keywords: |
Inventive step - no - obvious use of pharmaceuticals well known in the field of cancer therapy |
| Catchwords: |
-
|
| Cited decisions: |
|
| Citing decisions: |
|
2 references found.
Click
X to load a reference inside the current page, click on the title to open in a new page.
Case Law Book: II Conditions to be met by an Application
Loading...
Case Law of the Enlarged Board
Loading...